Initial Public Offering

Healthcare
Initial Public Offering

Summary

Baird served as a co-manager on this offering

About

Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) completed an initial public offering of 27,236,841 shares of common stock at a price of $40.00 per share, generating gross proceeds of approximately $1.1 billion. The Company intends to use the net proceeds from the offering to reduce its existing debt obligation and for general corporate purposes.

Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. The Company is positioned at the intersection of business services and healthcare and has operations in approximately 100 countries and has more than 27,000 employees. Quintiles uses the breadth and depth of its service offerings, its global footprint and its extensive therapeutic, scientific and analytics expertise to help the Company’s biopharmaceutical customers, as well as other healthcare companies, navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes. Quintiles is headquartered in Durham, North Carolina.

For additional information about this transaction, please contact:

Les Cheek 617-426-5789
Jeff Seaman 312-609-4687
Greg Ingram 415-627-3279
Chad Moore, CFA 312-609-5475
Satoshi Matsumoto 312-609-5446
Bill Suddath 404-264-2222
Healthcare
Initial Public Offering
Date
May 2013
Company
Quintiles Transnational Holdings Inc.
Transaction
M&A
Sectors
Healthcare
Target Location
North America

Share